Date of event - estimated.The unique device identifier (udi) is unknown because the part and lot numbers were not provided.Date of implant - estimated.The devices were not returned for evaluation.A review of the lot history records and complaint histories could not be conducted because the part and lot numbers were not provided.The reported patient effects of stenosis, myocardial infarction, and thrombosis, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use (ifu) are known adverse events associated with the use of a coronary scaffold in native coronary arteries.Based on the information reviewed, a conclusive cause for the reported patient effects could not be determined.The treatment appears to be related to the circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.Attachment article titled: "medium-term bioresorbable scaffold outcomes utilising data from an australian clinical quality registry".The deaths referenced in the article are filed under a separate medwatch report number.Na.
|
This is filed to report other serious injuries: it was reported through a research article, identifying the absorb bioresorbable vascular scaffold, that may be related to the following: patient death, myocardial infarction, restenosis, thrombosis, bleeding, revascularization, re-hospitalization and device deficiency of scaffold discontinuity.Details are listed in the attached article, titled medium-term bioresorbable scaffold outcomes utilising data from an australian clinical quality registry please see article for additional information.
|